GE Healthcare Life Sciences Hosts Graduate Students from Japan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

GE Healthcare Life Sciences Hosts Graduate Students from Japan



GE Healthcare Life Sciences has formed a joint program with Osaka University to offer students access to GE Healthcare’s training and technologies for biopharmaceutical research and manufacturing, to help support future growth of the sector in Japan.  The program, Interdisciplinary Program for Biomedical Sciences (IPBS), is Osaka University’s government-funded commitment to graduate education, which aligns with GE Healthcare Japan’s “Life Sciences Academy,” a GE Healthcare initiative launched in April 2013 with the objective of supporting the development of life sciences researchers in Japan.  Of the 14 IPBS graduate students, four will visit GE Healthcare Life Science’s Uppsala site for three weeks.

While at GE Healthcare in Uppsala, the Osaka University students will experience life in an R&D laboratory, closely working with GE Healthcare scientists and engineers. The students will receive comprehensive training in GE Healthcare’s advanced bioprocessing technologies and gain experience of protein interaction analysis and laboratory-scale protein purification using GE Healthcare instruments including Biacore and MicroCal systems for label-free analyses and ÄKTA pure chromatography systems.

Source: GE Healthcare Life Sciences

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here